| AFM28 - ADCP. |
| @joanna |
04/27/2023 4:11:19 PM |
| Some CEOs won't even PR. $AFMD was a |
| @qasimkareem |
04/27/2023 1:29:34 AM |
| A letter (dated April 4th) was received saying |
| @flowcab90 |
04/26/2023 3:50:11 AM |
| It has advantages as multiple edits can result |
| @Slapaix23 |
04/26/2023 3:10:01 AM |
| whytestocks: $FATE News Article - Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Finan |
| @ |
04/24/2023 6:20:48 PM |
| If you listen to $DTIL CSO who just |
| @grrlonfire |
04/22/2023 7:21:10 PM |
| TME is poorly understood. Mgt. is crossing a |
| @Ecarluccio |
04/22/2023 7:17:39 PM |
| Clearly active (I wonder if they plan to |
| @sayabonde |
04/22/2023 1:13:11 AM |
| An IIT (in China) testing this (using the |
| @SiulauDarba |
04/22/2023 1:06:17 AM |
| Depends on the edits. The authors go on |
| @CNAFInance |
04/22/2023 1:01:26 AM |
| Endless edits still doesn't address the infection that |
| @chocochobo |
04/20/2023 5:49:22 PM |
| What is the impact of multiple edits on |
| @jbarry |
04/20/2023 12:33:42 AM |
| Some more info on CLASH https://www.liebertpub.com/doi/10.1089/crispr.2023.0003 |
| @garrettwkfme |
04/19/2023 11:13:06 PM |
| The poster |
| @TheStockCrusader |
04/19/2023 7:34:24 PM |
| I was hoping they would have focused on |
| @ejjoe001 |
04/19/2023 7:30:11 PM |
| Out 6.60-6.65, $$$$$ |
| @blortnoy |
04/18/2023 7:08:51 PM |
| ICE that does ADCP has value. AFM 13 |
| @precisionairgunammo |
04/17/2023 12:10:38 AM |
| CAR NK looks like CART. What is the |
| @jameshebrew |
04/13/2023 2:04:51 PM |
| I can see why they chose the targets |
| @otcobserver |
04/11/2023 8:07:44 PM |
| In this, the authors show that iPSC-derived NKs |
| @Mstephen23 |
04/05/2023 9:59:32 PM |
| whytestocks: $FATE News Article - DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Fate Therapeutic |
| @ |
03/21/2023 12:35:48 PM |
| From twitter https://twitter.com/brendan_49/status/1636044757360164875 |
| @DoctorTampa |
03/17/2023 7:17:49 PM |
| (OT) Cellinfinity Bio will leverage proprietary, directed evolution, |
| @Maliksab |
03/16/2023 12:09:27 AM |
| Preclinical data on an anti-CXCR5 CAR https://www.nature.com/articles/s41467-020 |
| @nipsy516 |
03/15/2023 11:51:44 PM |
| Naturally, HLA-G blocks immune cell function by binding |
| @wdc888 |
03/15/2023 10:53:45 PM |
| (OT) CARTemis Therapeutics |
| @BestBuysell01 |
03/15/2023 10:36:53 PM |
| Have you seen this in gene modified NK |
| @Jester_vandalay |
03/15/2023 7:27:32 PM |
| whytestocks: $FATE News Article - 7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Fate Therapeu |
| @ |
03/15/2023 2:15:47 PM |
| CAT-248, an allogeneic CD70-directed CAR-NK cell therapy effectively |
| @derpyhuman |
03/15/2023 2:08:11 AM |
| (OT) Catamaran Bio will use healthy donor NK |
| @scottzman62 |
03/15/2023 2:06:25 AM |
| Engineered iPSC-derived NK cells as next-generation immunotherapies for |
| @Mattyhudz20 |
03/15/2023 1:44:20 AM |
| Identification of novel CAR transmembrane and endodomains for |
| @ezra2036 |
03/15/2023 1:41:18 AM |
| In this at 5.00 awhile back |
| @sal |
03/01/2023 1:31:34 PM |
| Whats the story behind these lawsuits? Any thoughts |
| @Krazy19 |
02/18/2023 4:15:53 AM |
| Yes, clinical data from AUTL's AUTO6* https://www.science.org/doi/10.1126/scitr |
| @scottzman62 |
02/17/2023 12:56:48 AM |
| On the 28th of this month, Q4 and |
| @benmoghadas26 |
02/16/2023 9:54:17 PM |
| CT041, an auto anti-CLDN18.2 CAR-T has shown promising |
| @Felgueiras |
02/16/2023 9:51:45 PM |
| whytestocks: $FATE News Article - Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full |
| @ |
02/13/2023 5:30:49 PM |
| Adding to the stash |
| @zmukry |
02/13/2023 12:39:16 PM |
| This CART is great, targeting is still a |
| @raynix |
02/11/2023 7:14:24 PM |
| CART, NK need partners that target the hypoxic |
| @dachamp4 |
02/10/2023 2:06:37 AM |
| TAMs alter NK cell phenotype and function in |
| @raynix |
02/08/2023 10:45:43 PM |
| I think all NK cells need a ICE |
| @Skinnerre |
02/06/2023 9:56:49 PM |
| Since the BCMA, CD19 space are too crowded, |
| @lostnfnd |
02/06/2023 9:54:04 PM |
| Well, not surprising. My view, both FT576 and |
| @DECKARMALLORY |
02/04/2023 8:25:49 PM |
| A PhI of FT538 (+/- vorinostat) for persistent |
| @swisstpa |
02/03/2023 11:52:03 PM |
| This stock is not liked by many analysts |
| @griffinrc |
02/03/2023 6:15:30 PM |
| (OT) Modulus Therapeutics, is engineering next-gen immune cell |
| @michaeljacobs |
02/03/2023 12:06:34 AM |
| They will target HLA-G https://nkilt.com/science/ |
| @mwaid |
02/02/2023 11:45:38 PM |
| whytestocks: $FATE News Article - HAGENS BERMAN Encourages Fate Therapeutics, Inc. (FATE) Investors with Signific |
| @ |
02/02/2023 5:55:50 PM |
| Nice pop today, was oversold imo |
| @rocky |
01/27/2023 10:15:31 PM |
| Sure, but still the same management who not |
| @stephe |
01/26/2023 10:27:15 PM |
| Could be a huge play here long term |
| @Jesseclark |
01/26/2023 12:29:51 AM |
| Bounced off support |
| @Ryguy |
01/25/2023 6:39:54 PM |
| Turning TAM into a trojan horse is way |
| @mattie |
01/22/2023 3:02:08 AM |
| whytestocks: $FATE News Article - FATE INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Fate Th |
| @ |
01/11/2023 8:05:48 PM |
| whytestocks: $FATE News Article - The Law Offices of Frank R. Cruz Announces Investigation of Fate Therapeutics, |
| @ |
01/11/2023 7:15:47 PM |
| whytestocks: $FATE News Article - Fate Therapeutics Features Multiple Novel Approaches to Eliminate Conditioning |
| @ |
12/13/2022 1:05:46 PM |
| whytestocks: $FATE News Article - Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2022 Finan |
| @ |
04/22/2022 7:35:51 PM |
| whytestocks: $FATE News Article - Fate Therapeutics Highlights Positive Interim Data from its Phase 1 Study of FT |
| @ |
06/04/2021 4:50:46 PM |
| whytestocks: $FATE News Article - Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full |
| @ |
02/19/2021 4:35:48 PM |
| whytestocks: $FATE News Article - Looking For The Best Biotech Stocks To Buy Now? 2 Up By Over 300% YTD |
| @ |
12/08/2020 7:46:19 PM |
| znewcar1: FATE 37% v6,4M c83.77 f87,2M H89.92 S82.7 12 months |
| @frankplayer |
12/08/2020 12:19:47 AM |
| whytestocks: $FATE News Article - Fate Therapeutics to Present at Jefferies Cell Therapy Virtual Summit |
| @ |
09/30/2020 4:20:48 PM |
| whytestocks: $FATE News Article - Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer |
| @ |
08/19/2020 6:00:48 PM |
| PoemStone: On watch. |
| @aetmaad |
12/09/2019 11:40:37 PM |
| znewcar1: FATE 41% v8,3M c19.32 f75M gap from 13.5 ish to 18 then pulled strong to 20.16 before finding S@19. |
| @tmvonah0 |
12/09/2019 11:03:16 PM |
| whytestocks: $FATE bears are running |
| @ |
11/12/2019 7:32:02 PM |
| PoemStone: $FATE breakout $5.00 |
| @Mkommen |
12/22/2017 10:08:39 PM |
| PoemStone: $FATE reverse head and shoulders |
| @jpstocks303 |
02/19/2017 11:20:06 PM |
| danrocks: FATE Stock is number 158 for the largest percentage gain out of 250 stocks. $FATE FATE is up +5.9 |
| @PramodKumr |
12/15/2015 7:43:41 PM |
| danrocks: FATE Stock is number 214 for the largest percentage gain out of 250 stocks. $FATE FATE is up +4.8 |
| @securingthebagg |
12/14/2015 7:06:33 PM |
| danrocks: FATE Stock is number 23 for the largest percentage gain out of 250 stocks. $FATE FATE is up +21.3 |
| @Depsua |
04/22/2015 7:28:46 PM |
| danrocks: FATE Stock is number 18 for the largest percentage gain out of 250 stocks. $FATE FATE is up +24.5 |
| @ck64220 |
04/21/2015 9:53:51 PM |
| danrocks: FATE Stock is number 62 for the largest percentage gain out of 250 stocks. $FATE FATE is up +15.5 |
| @Imalakepapa |
04/20/2015 5:30:28 PM |
| Jake13: FATE Stock year to date has changed +18.49% percent. +19.20% in the last 30 days. $FATE Fate Ther |
| @michelle |
04/18/2015 2:15:45 AM |
| danrocks: FATE Stock is number 65 for the largest percentage gain out of 250 stocks. $FATE FATE is up +14.1 |
| @yuennie |
04/18/2015 2:08:45 AM |
| chartguy89: FATE 5.96 Fate Therapeutics Inc Stock Charts $FATE Last Updated: 04/17/15 Last price: 5.96 To |
| @Depsua |
04/18/2015 2:04:17 AM |
| clayton: FATE 5.96 Fate Therapeutics Inc $FATE stock added to my watch list. Right now with FATE I am watc |
| @jdhrrh01 |
04/18/2015 12:59:25 AM |
| chartguy89: FATE 5.08 Fate Therapeutics Inc Stock Charts $FATE Last Updated: 03/05/15 Last price: 5.08 To |
| @Marketsensei |
03/06/2015 6:37:15 AM |
| Jake13: FATE Stock year to date has changed -0.60% percent. +3.73% in the last 30 days. $FATE Fate Therap |
| @marktsagli |
02/14/2015 10:19:38 AM |
| chartguy89: FATE 5.00 Fate Therapeutics Inc Stock Charts $FATE Last Updated: 02/13/15 Last price: 5.00 To |
| @alena1546 |
02/14/2015 9:42:47 AM |
| danrocks: FATE Stock is number 201 for the largest percentage gain out of 250 stocks. $FATE FATE is up +4.8 |
| @shugastix |
12/11/2014 7:01:32 PM |
| clayton: FATE 4.23 Fate Therapeutics Inc $FATE stock added to my watch list. Right now with FATE I am watc |
| @giannyny |
11/24/2014 4:12:04 PM |
| clayton: FATE 4.23 Fate Therapeutics Inc $FATE stock added to my watch list. Right now with FATE I am watc |
| @jhruk1951 |
11/22/2014 3:25:38 AM |
| Emylers: FATE 3.91 Fate Therapeutics Inc $FATE Hit a 52 week low of 3.91 Closing the day 11/10/14 at 3.91 -0. |
| @jprudh |
11/11/2014 3:38:02 AM |
| Emylers: FATE 4.05 Fate Therapeutics Inc $FATE Hit a 52 week low of 3.91 Closing the day 11/07/14 at 4.05 -0. |
| @Lanemyers |
11/08/2014 3:49:01 AM |